A quantitatively-modeled homozygosity mapping algorithm, qHomozygosityMapping, utilizing whole genome single nucleotide polymorphism genotyping data by Huqun* et al.
PROCEEDINGS Open Access
A quantitatively-modeled homozygosity mapping
algorithm, qHomozygosityMapping, utilizing
whole genome single nucleotide polymorphism
genotyping data
Huqun
1,2, Shun-ichiro Fukuyama
1†, Hiroyuki Morino
3, Hiroshi Miyazawa
1, Tomoaki Tanaka
1, Tomoko Suzuki
1,
Masakazu Kohda
4, Hideshi Kawakami
3, Yasushi Okazaki
4, Kuniaki Seyama
5, Koichi Hagiwara
1*†
From Asia Pacific Bioinformatics Network (APBioNet) Ninth International Conference on Bioinformatics
(InCoB2010)
Tokyo, Japan. 26-28 September 2010
Abstract
Homozygosity mapping is a powerful procedure that is capable of detecting recessive disease-causing genes in a
few patients from families with a history of inbreeding. We report here a homozygosity mapping algorithm for
high-density single nucleotide polymorphism arrays that is able to (i) correct genotyping errors, (ii) search for auto-
zygous segments genome-wide through regions with runs of homozygous SNPs, (iii) check the validity of the
inbreeding history, and (iv) calculate the probability of the disease-causing gene being located in the regions iden-
tified. The genotyping error correction restored an average of 94.2% of the total length of all regions with run of
homozygous SNPs, and 99.9% of the total length of them that were longer than 2 cM. At the end of the analysis,
we would know the probability that regions identified contain a disease-causing gene, and we would be able to
determine how much effort should be devoted to scrutinizing the regions. We confirmed the power of this algo-
rithm using 6 patients with Siiyama-type a1-antitrypsin deficiency, a rare autosomal recessive disease in Japan. Our
procedure will accelerate the identification of disease-causing genes using high-density SNP array data.
Background
Identification of the genetic factors underlying disease
causation provides crucial information for disease pre-
vention and treatment. Nevertheless, genetic factors
have not yet been elucidated for many diseases [1,2].
Homozygosity mapping [3] enables the detection of
recessive disease-causing genes in a few patients from
families with a history of inbreeding; this mapping tech-
nique is especially useful for the detection of rare genes.
With this technique, chromosomal segments in which
all polymorphic markers are homozyogous are consid-
ered autozygous segment (AS) [4]. If a patient’s
coefficient of consanguinity is F, and the frequency of
the disease-causing gene in the population is p, then the
chance that the recessive disease-causing gene is located
in an AS (PAS) is.
P
F
Fp F
AS =
−+ () 1
(1)
[3]
If a patient is from an inbred family (i.e., F is large)
and the disease is rare (i.e., p is small), then PAS≈ 1,
indicating that the gene is located in an AS. There are
implementations that utilize single-nucleotide poly-
morphism (SNP) genotyping data obtained by high-den-
sity arrays [5,6]. The usable implementation should (i)
correct genotyping errors because thousands of SNPs
are mistyped per high-density SNP array, adversely
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for ASs genome-wide; (iii) check the validity of the
inbreeding history, which is vital for homozygosity map-
ping but is often erroneous, and (iv) calculate the prob-
ability of the disease-causing gene being located in the
regions identified. At the end of the analysis, we would
know the probability that regions identified contain a
disease-causing gene, and we would be able to deter-
mine how much effort should be devoted to scrutinizing
the regions.
In the current study, we present an algorithm that
implements the capabilities described in the above
paragraph. We confirmed the power of this algorithm
using 6 patients with Siiyama-type a1-antitrypsin defi-
ciency, a rare autosomal recessive disease in Japan
[7,8]. The preliminary version of the algorithm
described here has been used to prove that the
SLC34A2 gene is responsible for pulmonary alveolar
microlithiasis [9]; the current version has been used to
show that the OPTN gene is responsible for amyo-
trophic lateral sclerosis [10].
Implementation
Crossover model
We used the Haldane’s Poisson process model for the
occurrence of crossovers and performed all calculations
based on this model [11]. Information on SNPs used by
Affymetrix’s Genome-Wide Human SNP Array 6.0
(hereafter referred to as SNP Array 6.0) was summarized
in the annotation file, [12], in which the genetic distance
from the telomere of the short arm of a chromosome to
each SNP was obtained by interpolation using the sex-
averaged data published by deCODE Genetics [13]. We
restricted our analysis to a total of 890,625 autosomal
SNPs with assigned dbSNP refIDs [14].
Monte Carlo simulation
The average number, the average length, and the maxi-
mal length of the ASs derived from a common ancestor
were calculated for a range of m + n values (Figure 1A)
using a Monte Carlo simulation. The trial was repeated
until we observed 100,000 events in which at least 1 AS
appeared in the autosomal region.
The length of AS
The subject is removed from the common ancestor m
generations on the paternal side and n generations on
the maternal side (Figure 1A). Assuming that the length
of each autosome is infinite, the length of AS conforms
to an exponential distribution with a probability density
function of
fx e
mn
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
100
1 (2)
In actuality, the autosomes have finite length; how-
ever, equation 2 provides a good approximation when
the length of an AS is much shorter than the length of
an autosome.
RHS (run of homozygous SNPs), false negative, type A
false positive and type B false positive
An RHS is defined as a run of homozygous SNPs with a
genetic length greater than the RHS cutoff value (Figure
1B). All SNPs in an AS are homozygous, and therefore
an RHS suggests the presence of an AS. We defined 3
types of errors. False negatives are ASs that are not con-
tained in RHSs. Type A false positives are RHSs that do
not contain ASs. Type B false positives are the spaces
within an RHS that do not contain an AS. The false
negative rate (Rfalse negative) is the ratio of false negatives
to the total length of the AS. The false positive rate
(Rfalse positive) is the ratio of false positives (the type A
false positives plus the type B false positives) to the total
length of the autosomes.
(1) Rfalse negative, the ratio of the total length of false
negatives to the total length of the AS
According to the equation 2,
R
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(2) RType A false positive, the ratio of the total length of
type A false positives to the total length of the
autosomes
Given that NSNP is the total number of SNPs on a
genotyping array, and Pn and Qn are the frequencies of
the major and minor alleles for the nth SNP, respec-
tively, then the average frequencies of the major alleles
( Fmajor allele) and the minor alleles ( Fminor allele ) are
F
Pn
n
NSNP
NSNP
F
Qn
n
NSNP
NSNP
major allele minor allele = =
∑
= =
∑
11 and ,
respectively. The numbers of homozygous SNPs (Nho-
mozygousSNP) and heterozygous SNPs (NheterozygousSNP)a r e
approximated by
NF N F N
N
ozygousSNP major allele Pt minor allele Pt
h
hom , ≈ () + ()
22
and
e eterozygousSNP major allele minor allele Pt FF N ≈ () () 2,
where Npt is the number of SNPs successfully geno-
typed. Assuming that heterozygous SNPs are randomly
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Page 2 of 11Figure 1 Connections between AS, RHS, false negative, type A false positive, and type B false positive values.( A )I naf a m i l yw i t ha
consanguineous marriage, a loop is formed in the pedigree (bold lines). A chromosomal segment that is separately inherited through both sides
of the arc becomes homozygous in an offspring and forms an autozygous segment. (B) (i) a chromosomal region with 2 ASs (dark gray boxes).
(ii) An RHS is a region whose genetic length greater than the cutoff value. (iii) Relationship of an RHS and an AS. ASs are shown by dark gray
boxes, and RHSs are shown by light gray boxes. Three types of errors are defined: false negative, type A false positive, and type B false positive.
(C) Principle used for the genotyping error correction. If a homozygous SNP in an RHS is mistyped and becomes heterozygous, it is likely to
have a greater distance (i.e. x + y) from the adjacent heterozygous SNPs than a heterozygous SNP that exists in another part of the autosomes.
Therefore, heterozygous SNPs with a large x +y are likely to be mistyped.
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Page 3 of 11located, then the length between 2 heterozygous SNPs
conforms to an exponential distribution with a probabil-
ity density function of
fx x
NheterozygousSNP
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1 (4)
where Lautosome is the entire length of the autosomes.
Therefore, at a cutoff value of c cM,
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(3) RType B false positive, the ratio of the total length of
type B false positives to the total length of the
autosomes
RType B false positive is not calculated mathematically but
is calculated according to the actual data. An RHS con-
taining an AS is expected to have type B false positives
with an average length of 1
2 ×
Lautosome
NheterozygousSNP on each
end. It is impossible to distinguish RHSs that contain
ASs from those that do not. We calculated RType B false
positive under the assumption that every RHS contains an
AS. Therefore, the RType B false positive calculation results
in an overestimation, which we consider better than an
underestimation for determination of the appropriate
RHS cutoff. Therefore,
R
number of RHS Lautosome
NheterozygousSNP
Type B falsepositive =×
2
. . (6)
(4) Rfalse positive, the ratio of the total length of false
positives to the total length of the autosomes
RR R falsepositive Type A falsepositive TypeB falsepositive =+
=+ (1
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Probability that a disease-causing gene is contained in
RHSs, or the overlap of RHSs
The probability that RHSs obtained contains a disease-
causing gene is calculated using equation 1.
PR P
R
F
GeneIsInRHS falsenegative AS
falsenegative
=− ×
=− ×
()
()
(
1
1
1− −+ Fp F )
.
(8)
Here, F is the coefficient of consanguinity and is cal-
culated by
F ≈
total length of RHSs
total length of the autosomes
. (9)
The probability that the overlap of RHSs among mul-
tiple patients contain the gene is calculated by
PP GeneIsInOverlap GeneIsInRHS
All patients
= ∏ . (10)
Human Subjects and genotyping
This study was approved by the Institutional Review
Boards of Saitama Medical University and Juntendo
University. After obtaining written informed consent,
DNA samples from 6 patients with a1-antitrypsin defi-
ciency were purified from peripheral blood. These
patients were not related and lived in different areas of
Japan. Patients 1-5 were from families with a history of
inbreeding because their parents were first cousins.
Patient 6 did not have any family history of inbreeding.
These 6 patients were genotyped using the SNP Array
6.0. The genotyping data for 86 HapMap JPT were
available in the HapMap3 draft release 2 http://www.
hapmap.org, and were downloaded from the Wellcome
Trust Sanger Institute web site http://www.sanger.ac.
uk/humgen/hapmap3/. The genotyping data for
NA18987, a subject in HapMap JPT, was also distribu-
ted from Affymetrix and was used in the current study.
Genotyping error correction
Genotyping errors may convert homozygous SNPs to
heterozygous SNPs and erroneously terminate an RHS,
resulting in the failure to detect a portion of an RHS.
According to Affymetrix, SNP Array 6.0 has an accu-
racy of > 0.997, implying that the genotyping error
rate (PgenotypingError) may be 0.003 at maximum. A mis-
typed heterozygous SNP occurring in an RHS is sepa-
rated by a large distance from neighboring
heterozygous SNPs (Figure 1C). Therefore, if a hetero-
zygous SNP is separated from neighboring SNPs by a
distance that is rarely observed by chance, we specu-
l a t e dt h a tt h eS N Pw a sm i s t y p e d .U s i n gequation 4,
we calculated the probability of a heterozygous SNP
being separated from neighboring SNPs at the
observed distance (PdistanceOccurredByChance). A SNP with
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SNP and these data were removed. This algorithm may
erroneously remove 20 correctly genotyped heterozy-
gous SNPs (NhomozygousSNP x PgenotypingError x 0.01) from
as i n g l eS N Pa r r a ya n a l y s i sd a t a ,w h i c hw ec o n s i d e r e d
acceptable.
Statistical analysis
The number of patients and controls who shared an
RHS at each SNP position was compared. The assump-
tion was made that
u
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. Here, x1
and x2 represent the numbers of patients and controls
sharing RHSs, respectively, and n1 and n2 represent the
total numbers of patients and controls, respectively. The
P value was calculated by
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Computer program
The computer program was written in the ANSI stan-
dard C programming language. The program was com-
piled by the GNU C compiler 4.2 and run on a
M a c B o o kP r o( C P U :2 . 5 3G H zI n t e lC o r e2D u o ,4G B
RAM) computer. The command line programs and the
programs equipped by graphic user interface are both
available from our web site at http://www.hhanalysis.
com.
Result
Strategy
Our aim was to establish an algorithm for homozygosity
mapping that uses SNP genotyping data obtained by
high-density arrays, is equipped by a powerful genotyp-
ing error correction algorithm, detects ASs genome-
wide, allows investigation into the family inbreeding his-
tory, and is able to calculate the probability that the
identified regions contain the target gene.
The algorithm searches for the ASs (Figure 1A, B(i))
through runs of homozygous SNPs, or RHSs, that are
formed by consecutively homozygous SNPs and are
longer than the RHS cutoff value (Figure 1B(ii)). RHSs
are presumably the autozygous segments (ASs). Three
types of errors were defined; false negative, type A false
positive, and type B false positive (Figure 1B(iii)). The
main determinants of the false negative rate (Rfalse negative),
which is the ratio of the total length of false negatives to
the total length of ASs, are the number of SNPs investi-
gated and the genotyping error rate. The main determi-
nants of the false positive rate (Rfalse positive), which is the
ratio of the total length of type A false positives plus type
B false positives to the entire length of the autosomes, are
the positioning of SNPs, local haplotype block structure
[15], and population substructure [16].
To attain the aims stated above while avoiding the
influence of these errors, our algorithm had the fol-
lowing steps: Step (a) determine an appropriate RHS
cutoff value based on the Haldane’s recombination
model; Step (b) perform genotyping error correction;
Step (c) detect RHSs; Step (d) obtain the overlaps of
RHSs among patients; and Step (e)c o r r e c tf a l s ep o s i -
tives by a case-control approach. The validity of the
family history is checked at Step (c).W eu s e d5
patients with Siiyama-type a1-antitrypsin deficiency, a
rare disease in Japan, to verify our strategy. Analyses
performed in the Result section can be reproduced
using the program contained in additional file 1
according to the tutorial also contained in the addi-
tional file 1.
Determination of the RHS cutoff
The expected false negative and false positive rates for
t h eS N PA r r a y6 . 0f r o mt h eH a l d a n e ’sm o d e lw e r ec a l -
culated by using equation 3 and 7 [Step (a)]( F i g u r e
2A). We gave the priority to reducing the false positive
rate than to reducing the false negative rate, because we
empirically determined that it simplified the analysis.
We chose 0.6 cM as the RHS cutoff value, at which the
false negative rate was 0.0006 and the false positive rate
was 0.0029. The probability that the RHSs contained the
disease-causing gene (PGeneIsInRHS) at this condition was
calculated using equation 8 (Figure 2B).
Genotyping error correction
The power of the genotyping error correction algorithm
was investigated using genotyping data for subject
NA18987 (female) from HapMap JPT. The subject was
independently genotyped in HapMap draft 3 and by
Affymetrix, and data were made public from both
sources. A comparison of these 2 datasets revealed that
the genotyping results for 701,753 SNPs matched
between these 2 sources, and they were therefore con-
sidered highly accurate. Using the matched data, RHSs
were obtained with an RHS cutoff value of 0.6 cM (Fig-
ure 3A). The presence of a long RHS (36.2 cM at
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Page 5 of 11Figure 2 Determination of the RHS cutoff and the probability that the disease-causing gene is contained in RHSs. (A) The false negative
rate (Rfalse negative) and the false positive rate (Rfalse positive) were calculated using equations 3 and 7 using the genotyping data for 5 a1-
antitrypsin deficiency patients. The false negative rate shown is for a child from a first-cousin marriage (m + n = 6). (B) The probability that RHSs
contain the disease gene (PGeneIsInRHS) calculated for a child from a first-cousin marriage. The coefficient of consanguinity (F) used was 1/16,
which was calculated according to Wright {Wright, S. Systems of Mating. V. General Considerations Genetics 1921: 6:167-178}. F can be more
precisely calculated as the total length of RHSs divided by the total length of the autosomes for the actual calculation (equation 9). PGeneIsInRHS
varies depending on the frequency of the gene in the population.
Figure 3 Genotyping error corrections. (A) RHSs for NA18987. (B) RHSs detected after introducing genotyping errors to 2,105 SNPs. (C) RHSs
after the genotyping error correction algorithm was applied.
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inbreeding, as described later. Considering the fact that
the manufacturer (Affymetrix) claimed that the genotyp-
ing error rate for the SNP Array 6.0 is less than 0.003,
we randomly introduced errors into selected 2,105 SNPs
(701,753 SNPs × 0.003) and obtained RHSs. These error
hampered the detection of RHSs, especially the long
ones (Figure 3B). Following application of the genotyp-
ing error correction algorithm (Figure 1C), RHSs were
restored (Figure 3C). The same trial repeated 100 times
revealed that the genotyping error correction restored
an average of 94.2% of the total length of all RHSs, and
99.9% of the total length of RHSs that were longer than
2 cM. This indicated that 99.9% of the total length of
ASs resulting from first- or second cousin marriages
would be correctly detected as RHSs after the correc-
tion. The total length of the regions that were erro-
neously detected as RHSs amounted to only 0.2% of the
total length of the autosomes. These results indicated
that the performance of the genotyping error correction
algorithm was excellent.
RHSs in the patients
We applied the genotyping error correction algorithm to
the data for 5 patients with Siiyama-type a1-antitrypsin
deficiency [Step (b)], and then obtained RHSs [Step (c)]
(Figure 4A-E). All patients had long RHSs, which were
likely to be the result of first-cousin marriages.
Figure 4 RHSs obtained for 5 patients with Siiyama-type a1-antitrypsin deficiency and the distribution of the longest AS obtained by
a Monte Carlo simulation. (A) - (E) RHSs for each patient. (F) The distribution of the length of the longest AS obtained by a Monte Carlo
Simulation. The distribution for 86 HapMap JPT patients is also shown in the right side.
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We investigated whether the RHSs obtained for each
patient were consistent with family history [Step (d)].
We focused on the size of the longest AS because they
are an index of the most recent occurrence of inbreed-
ing in the patient’s family (equation 2). The distribution
of the length of the longest AS is calculated by a Monte
Carlo simulation (Figure 4F). From this distribution we
are able to say that the family history of a first cousin
marriage (m + n = 6) is unlikely when the longest RHS
is less than 20.9 cM. The size of the longest RHS for
Patients 1-5 were consistent with what expected from
their family histories (Table 1).
Overlap of RHSs
We then obtained the overlaps of the RHSs for Patients 1-5
whose parents were first cousins [Step (d)]( F i g u r e5 A ) .
The probability that these regions contained the disease-
causing gene (PGeneIsInOverlap) was calculated by equation 10
and is shown in Figure 5B. The prevalence of Siiyama-type
a1-antitrypsin deficiency is less than 1 in a million in Japan,
and the frequency of the gene is suspected to be less than
0.001 in the general population, indicating that the overlaps
likely contained the disease-causing gene.
Some of the autosomal regions are prone to type A or
type B false positives, and thus are likely to appear as an
overlap [Step (e)]. To prioritize regions for in-depth
analysis, we performed a case-control study using 86
HapMap JPT subjects as controls. One overlap had the
largest -log10( P )v a l u e( 1 6 . 4 7 )a n dw a sc o n s i d e r e dt ob e
the candidate region (Figure 5C). This region (between
Table 1 Size of the longest RHS for each patient
Length of the longest RHS (cM)
Patient 1 36.2
Patient 2 39.6
Patient 3 22.1
Patient 4 40.3
Patient 5 30.2
Figure 5 Case-control analysis. (A) The overlaps of RHSs for Patients 1-5. (B) The probability that the disease-causing gene is contained in the
overlap (PGeneIsInRhsOverlap). The probability was calculated by multiplying PGeneIsInRHS for Patients 1-5. F for each patient was calculated as the total
length of RHSs divided by the total length of the autosomes. (C) -log10(P) value obtained by a case-control analysis. The region pointed by an
arrow attained the maximal value 16.47.
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cM, and contained 15 genes (Table 2), one of which was
the disease-causing gene for Siiyama-type a1-antitrypsin
deficiency, SERPIN1.
A patient without family history of inbreeding
We occasionally encounter patients who do not have a
family history of inbreeding while searching for a
recessive disease-causing gene. Data from such patients
are not used in the main analysis, but these data may be
used for prioritizing the overlaps of RHSs as obtained in
Figure 5 for an in-depth search. Patient 6 had Siiyama-
type a1-antitrypsin deficiency but did not have a family
history of inbreeding. The length of the longest RHS
( 6 . 8c M ,F i g u r e6 A )w a so u t s i d eo ft h e9 5 %r a n g ef o r
the Japanese population (Figure 4F, rightmost bar and
Table 2 Genes present in the candidate RHS overlap
C14orf48 chromosome 14 open reading frame 48
OTUB2 OTU domain, ubiquitin aldehyde binding 2
DDX24 DEAD (Asp-Glu-Ala-Asp) box polypeptide 24
IFI27L1 interferon, alpha-inducible protein 27-like 1
IFI27 interferon, alpha-inducible protein 27
IFI27L2 interferon, alpha-inducible protein 27-like 2
PPP4R4 protein phosphatase 4, regulatory subunit 4
SERPINA10 serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10
SERPINA6 serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6
LOC10028 Description: hypothetical protein LOC100287997
SERPINA2 serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 2
SERPINA1 serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
SERPINA11 serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 11
SERPINA9 serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 9
SERPINA12 serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12
Figure 6 Subject without family history of inbreeding. (A) RHSs obtained for a patient without a family history of inbreeding (Patient 6). (B)
RHS overlaps for Patients 1-6. Addition of data for Patient 6 further narrowed the overlapped regions (compare with Figure 5). The disease-
causing gene was contained in the region indicated by a white arrow. (C) -log10(P) value obtained by a case-control analysis. The region pointed
by an arrow attained the maximal value 17.29.
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have had forgotten inbreeding history, and that the
RHSs for the patient may have a high probability of
containing the disease-causing gene. This was indeed
the case; addition of the data from Patient 6 excluded
several overlapped regions (Figure 6B, compare with
Figure 5A) and increased -log10(P) (Figure 6C, compare
with Figure 5C), although the list of the genes was the
same as Table 2. If the length of the longest RHS sug-
gested a hidden inbreeding history, the data for subjects
without an inbreeding history could be used to prioritize
some RHS overlaps for an in-depth search.
Discussion
In the current report, we described the quantitatively-
modeled homozygosity mapping algorithm that uses
high density array SNP genotyping data.
Homozygosity mapping is simple in principle, but many
pitfalls were discovered when it was actually applied. Pro-
blems that included (i) unexpected allelic heterogeneity,
(ii) identification of a homozygous identical-by-descent
(IBD) region to the disease locus, (iii) underestimation of
the extent of inbreeding, were pointed out in the analyses
using microsatellite markers [17] and are still observed in
the analyses using SNPs. Moreover, use of high-density
SNP arrays introduced a novel problem, (iv) a large num-
ber of mistyped SNPs. Although the genotyping error rate
is low for high-density arrays, the huge number of SNPs in
these arrays inevitably produces a large number of mis-
typed SNPs. Even a single mistyped SNP erroneously ter-
minates an RHS, making the detection of large RHSs
difficult. Our algorithm has overcome all these problems:
problem (i) is solved by using high-density SNP arrays,
problem (ii) by case-control approach, problem (iii) by
identifying ASs as RHSs and calculating F by the total
length of RHSs divided by the total length of the auto-
somes, and problem (iv) by applying genotyping error cor-
rection algorithm.
As stated as Problem (ii) above, we observed some
autosomal regions had a high probability of having
RHSs. This may be caused by SNP positioning, local
haplotype block structure, or population substructure.
The effect of them was eliminated by using a case-con-
trol approach, which is performed in the order that (a)
obtain overlap of RHS among patients, and (b) perform
a case-control analysis targeting obtained overlaps.
Homozygosity mapping has power to identify a disease-
causing gene in as few as 3 patients, and we have indeed
identified the SLC34A2 gene in pulmonary alveolar micro-
lithiasis and the OPTN gene in the amyotrophic lateral
sclerosis both in 3 patients [9,10]. Amyotrophic lateral
sclerosis has multiple causative genes. In the latter report,
we were able to identify one of the genes by investigating
each combination of 3 patients from 7 patients with a
history of inbreeding, seeking for 3 patients harboring the
same disease-causing gene. Our algorithm worked fine in
this approach. During the process, it was quite helpful that
the algorithm provided the probability that the identified
regions contain the disease-causing gene, which deter-
mined how much effort should be further devoted. To our
knowledge, the algorithm presented in the current study is
the first to provide this information.
Conclusions
We described an algorithm that enables homozygosity
mapping to be performed based on a quantitative model
using SNP genotyping data. Our procedure will acceler-
ate the identification of disease-causing genes using
high-density SNP array data.
Availability and requirements
Project name: qHomozygosityMapping
Project home page: http://www.hhanalysis.com
Operating system(s): Mac, Linux and Windows.
Programming language: C
License: GNU GPL.
Any restrictions to use by non-academics: The soft-
ware is for academic purpose only.
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